SCHEMBL14045830

SCHEMBL14045830

Cc1ccc(S(=O)(=O)NC(C(=O)ON)C(C)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.57
SLC1A2 P43004 1/20 0.57
SLC1A1 P43005 1/20 0.57
MMP9 P14780 7/20 0.56
MMP1 P03956 6/20 0.56
MMP13 P45452 6/20 0.56
MMP2 P08253 5/20 0.56
MMP7 P09237 4/20 0.56
MMP3 P08254 3/20 0.56
PLAU P00749 1/20 0.49
HPN P05981 1/20 0.49
CA9 Q16790 3/20 0.48
CA12 O43570 2/20 0.48
CA14 Q9ULX7 1/20 0.48
CA2 P00918 4/20 0.47
TSHR P16473 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CA1 P00915 3/20 0.46
CA7 P43166 1/20 0.46
MMP8 P22894 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14045736 0.85 ADAMTS4 (0.64) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL6296214 0.83 MMP9 (0.73) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL6302637 0.83 MMP9 (0.73) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL21538657 0.83 MMP9 (0.73) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL14045788 0.82 NPSR1 (0.48) MMP9MMP1MMP13MMP2MMP7
SCHEMBL4916984 0.81 MMP9 (0.60) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL14025839 0.81 MMP9 (0.60) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL14045734 0.80 SLC1A2 (0.46) SLC1A3SLC1A2SLC1A1MMP9MMP1
SCHEMBL14045868 0.80 SLC1A3 (0.60) SLC1A3SLC1A2SLC1A1MMP9MMP13
SCHEMBL30689139 0.79 ALDH1A1 (0.54) SLC1A3SLC1A2SLC1A1MMP9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 SLC1A3 217/4885SLC1A2 434/4885SLC1A1 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.